McKesson Corporation (MCK)
Working capital turnover
Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 308,734,000 | 276,496,000 | 263,638,000 | 238,047,000 | 230,835,000 |
Total current assets | US$ in thousands | 47,970,000 | 44,292,000 | 46,231,000 | 45,382,000 | 42,222,000 |
Total current liabilities | US$ in thousands | 52,357,000 | 47,957,000 | 48,466,000 | 44,103,000 | 42,624,000 |
Working capital turnover | — | — | — | 186.12 | — |
March 31, 2024 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $308,734,000K ÷ ($47,970,000K – $52,357,000K)
= —
The working capital turnover ratio for McKesson Corporation in 2021 was 186.12, indicating that the company generated $186.12 in net sales revenue for every dollar of working capital invested in the business during that fiscal year. The absence of data for the other years restricts the ability to provide a trend analysis or comparisons with previous periods. A higher working capital turnover ratio typically suggests that a company efficiently utilizes its working capital to generate sales revenue.
Peer comparison
Mar 31, 2024
Company name
Symbol
Working capital turnover
McKesson Corporation
MCK
—
Cardinal Health Inc
CAH
—
Cencora Inc.
COR
—
Nu Skin Enterprises Inc
NUS
5.21